Merck KGaA
MKKGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $21 | $21 | $22 | $20 |
| % Growth | 0.8% | -5.6% | 12.9% | – |
| Cost of Goods Sold | $9 | $9 | $9 | $7 |
| Gross Profit | $12 | $12 | $14 | $12 |
| % Margin | 59% | 59% | 61.6% | 62.7% |
| R&D Expenses | $2 | $2 | $3 | $2 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $5 | $5 | $5 | $5 |
| Sales & Mktg Exp. | $4 | $4 | $4 | $4 |
| Other Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Expenses | $9 | $9 | $9 | $8 |
| Operating Income | $4 | $4 | $4 | $4 |
| % Margin | 17.2% | 17.2% | 20.1% | 21.2% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $4 | $3 | $4 | $4 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | $3 | $3 | $3 | $3 |
| % Margin | 13.1% | 13.5% | 15% | 15.5% |
| EPS | 1.28 | 1.3 | 1.53 | 1.41 |
| % Growth | -1.5% | -15% | 8.5% | – |
| EPS Diluted | 1.28 | 1.3 | 1.53 | 1.41 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | $6 | $6 | $6 | $6 |
| % Margin | 28.2% | 27.1% | 28.2% | 29.9% |